Email this article 
Post a Comment Effectiveness of nephrolithiasis surgical treatment on the background of replacement testosterone therapy
- Authors: Tagirov N.S.1
-
Affiliations:
- St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation
- Issue: Vol 10, No 2 (2019)
- Pages: 47-54
- Section: Articles
- URL: https://ogarev-online.ru/pediatr/article/view/13512
- DOI: https://doi.org/10.17816/PED10247-54
- ID: 13512
Cite item
Full Text
Abstract
The goal of the study is to assess the effectiveness and safety of testosterone replacement therapy in males with androgenic deficiency and nephrolithiasis who require surgical treatment.
Patients and methods. All in all 565 patients were involved in the study. In 226 of them (40%) surgical treatment was used. In a majority of these cases (90%) contact uretherolithotripsy was used. In half of the patients uretheroscopy had revealed large and long-lasting concrements. In order to assess the effectiveness of nephrolithiasis surgical treatment on the background of testosterone replacement treatment the assessment of hormonal status during pre- and postoperative periods was accomplished, duration and intensity of pain during the early post-operative period was evaluated as well as narcotic analgetics application frequency and the duration of antibacterial therapy and the stay in the hospital.
Results of the study. Replacement testosterone therapy during the early postoperative period in male patients with nephrolithiasis and androgen deficit has been demonstrated to reduce the leukocyteuria duration and the need for antibacterial therapy thus decreasing the stay at the hospital. Replacement testosterone therapy in male patients with nephrolithiasis and androgen deficit who had dealt with surgical treatment has been shown to decrease the pain duration and intensity thus decreasing the need for narcotic analgetics. The use of replacement testosterone therapy in the complex treatment of nephrolithiasis in patients after surgery contributes to faster liquidation of hyperglycemia and normalization of carbohydrate metabolism. Replacement testosterone therapy in male patients with androgen deficit and nephrolithiasis who need surgical treatment contributes to reduction of kidney stone disease relapse rate.
Conclusion. Replacement testosterone therapy in male patients with nephrolithiasis and androgen deficit who need surgical treatment considerably improve the postoperative period quality.
Full Text
##article.viewOnOriginalSite##About the authors
Nair S. Tagirov
St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: ruslana73nair@mail.ru
Associate Professor of Pathophysiology Department
Russian Federation, Saint PetersburgReferences
- Аль-Шукри С.Х., Аммо Р.М., Ткачук В.Н. Повреждающее действие ударной волны при выполнении дистанционной ударно-волновой литотрипсии у больных нефролитиазом // Нефрология. – 2013. – Т. 17. – № 1. – С. 78–83. [Al-Shukri SK, Ammo RM, Tkachuk VN. Shock wave damaging effect at carrying out extracorporeal shock wave lithotripsy in patients with nephrolithiasis. Nephrology. 2013;17(1):78-83. (In Russ.)]
- Васильев А.Г., Комяков Б.К., Тагиров Н.С., Мусаев С.А. Чрескожная нефролитотрипсия в лечении коралловидного нефролитиаза // Вестник Санкт-Петербургской государственной медицинской академии им. И.И. Мечникова. – 2009. – № 4. – С. 183–186. [Vasiliev AG, Komyakov BK, Tagirov NS, Musaev SA. Percutaneous nephrolithitripsy in the treatment of coral calculus nephrolithiasis. Transactions of the leningrad medical institute of sanitation and hygiene. 2009;(4):183-186. (In Russ.)]
- Васильев А.Г., Заславский Д.В., Трашков А.П., и др. Изменения гормонального статуса у пациентов с очаговым вульгарным псориазом // Вестник дерматологии и венерологии. – 2011. – № 5. – С. 88–90. [Vasiliyev AG, Zaslavsky DV, Trashkov AP. Changes in the hormonal status of patients with focal psoriasis vulgaris. Vestn Dermatol Venerol. 2011;(5):88-90. (In Russ.)]
- Тагиров Н.С., Назаров Т.Х., Васильев А.Г., и др. Опыт применения чрескожной нефролитотрипсии и контактной уретеролитотрипсии в комплексном лечении мочекаменной болезни // Профилактическая и клиническая медицина. – 2012. – № 4. – С. 30–33. [Tagirov NS, Nazarov TH, Vasilev AG. The experience of using percutaneous nephrolithotripsy and contact ureterolithotripsy in the complex treatment of urolithiasis. Preventive and clinical medicine. 2012;(4):30-33. (In Russ.)]
- Трашков А.П., Панченко А.В., Каюкова Е.С., и др. Лейкемия Р-388 у мышей линии CDF1 как тест-система опухоль-ассоциированного неоангиогенеза и гиперкоагуляции // Бюллетень экспериментальной биологии и медицины. – 2014. – Т. 158. – № 10. – С. 500–502. [Trashkov AP, Panchenko AV, Kayukova ЕS, et al. Leykemiya R-388 u myshey linii CDF1 kak test-sistema opukhol’-assotsiirovannogo neoangiogeneza i giperkoagulyatsii. Biull Eksp Biol Med. 2014;158(10)500-502. (In Russ.)]
- Трашков А.П., Васильев А.Г., Коваленко А.Л., Тагиров Н.С. Метаболическая терапия мочекаменной болезни на различных моделях поражения почек у крыс // Экспериментальная и клиническая фармакология. – 2015. – Т. 78. – № 3. – С. 17–21. [Trashkov AP, Vasiliev AG, Kovalenko AL, Tagirov NS, et al. Metabolic therapy of nephrolithiasis in two different rat models of kidney disease. Experimental and clinical pharmacology. 2015;78(3):17-21. (In Russ.)]
- Anaissie J, Roberts NH, Wang P, Yafi FA. Testosterone replacement therapy and components of the metabolic syndrome. Sex Med Rev. 2017;5(2):200-210. https://doi.org/: 10.1016/j.sxmr.2017.01.003.
- Akerman J, Kovac JR, Lipshultz LI. Testosterone therapy improves well being and psychological health. Curr Opin Urol. 2017;27(6):519-524. https://doi.org/: 10.1097/MOU.0000000000000440.
- Catakoglu AB, Kendirci M. Testosterone replacement therapy and cardiovascular events. Turk Kardiyol Dern Ars. 2017;45(7):664-672. https://doi.org/: 10.5543/tkda.2017.00531.
- Diemer T, Hauptmann A, Wagenlehner FM. [Testosterone therapy]. Urologe A. 2016;55(4):539-548; quiz 549-550. https://doi.org/: 10.1007/s00120-016-0072-y.
- Fisang C, Anding R, Muller SC, et al. Urolithiasis — an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Dtsch Arztebl Int. 2015;112(6):83-91. https://doi.org/: 10.3238/arztebl.2015.0083.
- Gee HY, Jun I, Braun DA, et al. Mutations in SLC 26A1 cause nephrolithiasis. Am J Hum Genet. 2016;98(6):1228-1234. https://doi.org/: 10.1016/j.ajhg.2016.03.026.
- Goodale T, Sadhu A, Petak S, Robbins R. Testosterone and the heart. Methodist Debakey Cardiovasc J. 2017;13(2): 68-72. https://doi.org/: 10.14797/mdcj-13-2-68.
- Hwang K, Miner M. Controversies in testosterone replacement therapy: testosterone and cardiovascular disease. Asian J Androl. 2015;17(2):187-191. https://doi.org/: 10.4103/1008-682X.146968.
- Kaplan AL, Hu JC, Morgentaler A, et al. Testosterone therapy in men with prostate cancer. Eur Urol. 2016;69(5):894-903. https://doi.org/: 10.1016/j.eururo.2015.12.005.
- Levcikova M, Breza J, Jr., Luha J, et al. Testosterone replacement therapy (TRT) and its effect on bone marrow. How serious is it and is there a true polyglobulia? Bratisl Lek Listy. 2017;118(11):654-657. https://doi.org/: 10.4149/BLL_2017_124.
- Lee OD, Tillman K. An overview of testosterone therapy. Am J Mens Health. 2016;10(1):68-72. https://doi.org/: 10.1177/1557988314556671.
Supplementary files
